Julie M. Fleshman, JD, MBA

PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

Anne-Marie Duliege, MD

PanCAN Chief Medical Officer, responsible for the strategic direction and operational oversight of the organization’s clinical initiatives, including PanCAN’s Precision Promise^SM clinical trial. Expertise in Hematology, Immunology, Nephrology & Infectious Diseases

Shubham Pant, MD

PanCAN Precision Promise Site Principal Investigator, Associate Professor in the Department of Gastrointestinal Medical Oncology, Associate Professor in the Phase I Department, The University of Texas MD Anderson Cancer Center

Jose G. Trevino MD, FACS

Walter E. Lawrence Jr. Distinguished Professor of Surgical Oncology, Chair of the Division of Surgical Oncology, Associate Professor of Surgery, Surgeon-in-Chief, Virginia Commonwealth University Massey Cancer Center

Ira Sharp, MD

Eight-year pancreatic cancer survivor, PanCAN volunteer